상세 보기
A Phase II study of Tepotinib in patients with advanced solid cancers harboring MET exon 14 skipping mutations or amplification (KCSG AL19-17)
16th annual meeting of the Korean Society of Medical Oncology & International Conference
- 제목
- A Phase II study of Tepotinib in patients with advanced solid cancers harboring MET exon 14 skipping mutations or amplification (KCSG AL19-17)
- 제목 (타언어)
- 16th annual meeting of the Korean Society of Medical Oncology & International Conference
- 저자
- Kang Eun Joo
- 발행일
- 2023-09-07
- 학회명
- 16th annual meeting of the Korean Society of Medical Oncology & International Conference
- 개최국가
- 대한민국
- 학회 개최일
- 2023-09-07 ~ 2023-09-08